Kyong-Oh Shin

Kyong-Oh Shin

Auto-generated profile, based on publicly available information

Kyong-Oh Shin

Department of Food Science and Nutrition, Convergence Program of Material Science for Medicine and Pharmaceutics Hallym University Chuncheon Republic of Korea

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2025 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
KSKyong‐Oh Shin
Kyong‐Oh Shin
JLJun Ho Lee
Jun Ho Lee
SCSeungwoo Chae
Seungwoo Chae
KGKarin Goto
Karin Goto
HAHahyun An
Hahyun An
KPKyungho Park
Kyungho Park
Epidermal permeability barrier defects are associated with several skin diseases, including atopic dermatitis (AD). Using an AD mouse model, we previously demonstrated that topically administered small extracellular vesicles (sEVs) (prepared following the International Society of Extracellular Vesicles recommendations) from human adipose tissue‐derived mesenchymal stem cells (ASC) ameliorate skin inflammation and normalize barrier function in parallel with increased ceramide (a key barrier lipid) production. To elucidate how ASC‐sEVs alleviate these AD skin abnormalities, we characterized lipids and ceramide metabolic enzymes in ASC‐sEVs versus donor ASCs. Our study revealed that free fatty acid, ceramide, and sphingomyelin are enriched in ASC‐sEVs versus donor ASCs, while the synthetic enzymes of ceramide (and acidic sphingomyelinase), and sphingosine‐1‐phosphate (sphingosine kinase) are significantly higher in ASC‐sEVs versus donor ASCs. Conversely, ceramide (ceramidase), and sphingosine‐1‐phosphate hydrolytic enzymes (sphingosine‐1‐phosphate lyase and sphingosine‐1‐phosphate phosphatase) are lower in ASC‐sEVs, suggesting that ceramide and sphingosine‐1‐phosphate levels could elevate in cells that receive ASC‐sEVs. ASC‐sEV‐mediated increases in sphingosine‐1‐phosphate suppress pro‐inflammatory cytokine production in AD‐model human keratinocytes. Additionally, keratinocyte differentiation, which is required for a competent epidermal permeability barrier, was restored in AD‐model human keratinocytes treated with ASC‐sEVs. Taken together, cells that endocytose ASC‐sEVs can normalize epidermal permeability barrier function as well as alleviate inflammation by stimulating a sphingosine‐1‐phosphate signalling pathway.

2 October 2013 in Archives of Pharmacal Research
Verified
Journal Article
Closed access
PDF file
DSDong-Mi Shin
Dong-Mi Shin
KCKyeong-Mi Choi
Kyeong-Mi Choi
YLYoun-Sun Lee
Youn-Sun Lee
WKWonkyun Kim
Wonkyun Kim
KSKyong-Oh Shin
Kyong-Oh Shin
HYHwan-Soo Yoo
Hwan-Soo Yoo

10 November 2023 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
KSKyong-Oh Shin
Kyong-Oh Shin
BKBokyung Kim
Bokyung Kim
YCYerim Choi
Yerim Choi
YBYoo-Jin Bae
Yoo-Jin Bae
Jae-Ho ParkJae-Ho Park
Jae-Ho Park
KPKyungho Park
Kyungho Park

1 January 2020 in Annals of Dermatology
Verified
Journal Article
Open access
PDF file
BCBo Young Chung
Bo Young Chung
HKHye One Kim
Hye One Kim
SKSeok Young Kang
Seok Young Kang
MJMin Je Jung
Min Je Jung
Sung Woo KimSung Woo Kim
Sung Woo Kim
CPChun Wook Park
Chun Wook Park
Chung BY, et al. Ann Dermatol. 2020 Aug;32(4):306-318. https://doi.org/10.5021/ad.2020.32.4.306

30 August 2024 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
KPKyungho Park
Kyungho Park
KSKyong-Oh Shin
Kyong-Oh Shin
YKYoung-Il Kim
Young-Il Kim
ANAnna L. Nielsen-Scott
Anna L. Nielsen-Scott
CMCarine Mainzer
Carine Mainzer
YUYoshikazu Uchida
Yoshikazu Uchida

1 January 2025 in Clinical Hypertension
Verified
Journal Article
Open access
PDF file
MLMinyoung Lee
Minyoung Lee
SPSungha Park
Sungha Park
SPSoo Hyun Park
Soo Hyun Park
HPHo-Young Park
Ho-Young Park
YLYu Ra Lee
Yu Ra Lee
KPKyungho Park
Kyungho Park
Lee M, et al. Clin Hypertens. 2025 Oct;31(1):e28. https://doi.org/10.5646/ch.2025.31.e28